Systematic review / meta-analysis / 2019
Cumulative meta-analysis shows soy consistently lowers total and LDL cholesterol over time.
In a cumulative meta-analysis of 46 randomized controlled trials evaluated by the FDA, soy consumption consistently lowered blood lipids over 14 years. For LDL cholesterol, average decreases were -6.3 mg/dL (95% CI: -8.7 to -3.9 mg/dL; P=0.00001) in 1999 and subsequently spanned -4.2 to -6.7 mg/dL (P=0.0006 to P=0.0002). Total cholesterol reductions also preserved statistical significance across all evaluated time points.
- Study type
- Cumulative meta-analysis of randomized controlled trials
- Who was studied
- 46 randomized controlled trials identified by the FDA
- What was measured
- Total and LDL cholesterol
THE PAPER
Cumulative Meta-Analysis of the Soy Effect Over Time.
Jenkins DJA, Blanco Mejia S, Chiavaroli L, Viguiliouk E, Li SS, Kendall CWC, Vuksan V, Sievenpiper JL. J Am Heart Assoc, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.